Post Tagged with: "T2-T11 level"

StemCells Gains as Data Show More Transplant Patients Have Sensory Function Gains in Spinal Cord

May 27, 2014 at 2:41 pm 0 comments

StemCells (STEM) shares were higher in recent pre-market trade after saying that data shows that significant post-transplant gains in sensory function first reported in two patients have now been observed in two additional patients. STEM was up 4.3% at $1.45 recently. It is trading below the mid-point of the 52-week rangeRead More